Clinical Trial

A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to assess the diagnostic efficacy (specificity and sensitivity) of 99mTc-4BOH SPECT myocardial perfusion imaging (MPI) compared to 13N-ammonia PET MPI in the detection of significant coronary artery disease (CAD) as defined by invasive coronary angiography (ICA).
Trial Details
NCT Number NCT06980194
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions Coronary Artery Disease
Enrollment 300 participants
Start Date 2025-08-01
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-20